Literature DB >> 25133644

A randomized trial comparing time intervals from HCG trigger to intrauterine insemination for cycles utilizing GnRH antagonists.

Amir Weiss1, Ronit Beck-Fruchter, Michal Lavee, Yoel Geslevich, Joanne Golan, Anna Ermoshkin, Eliezer Shalev.   

Abstract

Intrauterine insemination (IUI) during ovarian stimulation cycles is typically performed 36 hours after human chorionic gonadotropin (hCG) injection. We hypothesized that adjusting the time interval to IUI to better coincide with ovulation may increase pregnancy rates. Patients undergoing induction of ovulation utilizing gonadotropins and gonadotropin releasing hormone (GnRH) antagonists and IUI were divided to three groups based on the time from hCG injection to IUI: 36, 42, and 48 hours. Primary outcome was defined as the clinical pregnancy rate. Secondary outcomes comprised additional parameters including multifetal pregnancy rate. A total of 92 patients completed the study. Baseline parameters were similar between the groups. The clinical pregnancy rate in the three groups was 20%, 38%, and 24%, respectively. While the 42 hour time interval had a higher numerical pregnancy rate, the pregnancy rates did not differ statistically among the study groups. The multifetal pregnancy rate did not differ among the three groups as well. A larger study is necessary to ascertain if a 42 hour time interval can indeed improve pregnancy rates.

Entities:  

Keywords:  Gonadotropins; infertility; intrauterine insemination; ovarian stimulation

Mesh:

Substances:

Year:  2014        PMID: 25133644     DOI: 10.3109/19396368.2014.951457

Source DB:  PubMed          Journal:  Syst Biol Reprod Med        ISSN: 1939-6368            Impact factor:   3.061


  2 in total

1.  Comparing the Effectiveness of Doing Intra-uterine Insemination 36 and 42 Hours After Human Chorionic Gonadotropin (HCG) Injection on Pregnancy Rate: A Randomized Clinical Trial.

Authors:  Mahboubeh Firouz; Narjes Noori; Marzieh Ghasemi; Alireza Dashipour; Narjes Keikha
Journal:  J Family Reprod Health       Date:  2020-09

2.  Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination.

Authors:  Binarwan Halim; Hilma Putri Lubis
Journal:  Obstet Gynecol Sci       Date:  2022-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.